CFDE Data Portal | Search RPL11P1

	Label	Description
	RPL11P1 Gene (Entity type)	ENSG00000227394 - ribosomal protein L11 pseudogene 1
	GSE217085 L-25 HeLa 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128076 doxycycline HEK293 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 6 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128076 doxycycline HEK293 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147816 GSE147817 LSD1 inhibition McCoy 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx SmallIntestine 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx SalivaryGland 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Lung 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Lung 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx

RPL11P1

ENSG00000227394 - ribosomal protein L11 pseudogene 1

GSE217085 L-25 HeLa 1 v 0 human up

A Gene Set from LINCS

GSE128076 doxycycline HEK293 2 v 0 human up

A Gene Set from LINCS

GSE199107 tryptophan 6 v 2 human up

A Gene Set from LINCS

GSE128076 doxycycline HEK293 2 v 3 human up

A Gene Set from LINCS

GSE147816 GSE147817 LSD1 inhibition McCoy 3 v 2 human dn

A Gene Set from LINCS

GTEx SmallIntestine 20-29 vs 40-49 Down

A Gene Set from GTEx

GTEx SalivaryGland 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Lung 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Lung 20-29 vs 50-59 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.